{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-023828","form_type":"8-K","ticker":"IBEX","cik":"0001720420","company_name":"IBEX Ltd","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.462679+00:00","generated_at":"2026-05-22T04:56:48.091287+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IBEX reports record Q3 revenue $140.7M (+11% YoY), raises FY guidance, authorizes $15M buyback","bullets":["Revenue $140.7M, +11% YoY; adjusted EPS $0.82 (+18% YoY), both quarterly records.","GAAP diluted EPS $0.73 vs $0.57; net income $10.5M (+1.5%).","Raised FY2025 revenue guidance to $540-545M (prev. $525-535M); adj. EBITDA $68-70M.","Board authorized $15M share repurchase plan starting May 12, 2025.","Strategic entry into India with a healthcare client; 4 new logo wins in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-023828","json":"https://secwatch.observer/filing/0001628280-25-023828.json","markdown":"https://secwatch.observer/filing/0001628280-25-023828.md","text":"https://secwatch.observer/filing/0001628280-25-023828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720420/000162828025023828/0001628280-25-023828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720420/000162828025023828/ibex-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:56:48.091287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}